Wealthspire Advisors (New York)’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,158
Closed -$14.7K 2940
2025
Q3
$14.7K Buy
+1,158
New +$16.8K ﹤0.01% 1840
2021
Q2
Sell
-4,210
Closed -$269K 682
2021
Q1
$269K Sell
4,210
-840
-17% -$48.7K 0.01% 585
2020
Q4
$264K Buy
+5,050
New +$249K 0.01% 475
2020
Q2
Sell
-6,556
Closed -$255K 541
2020
Q1
$255K Buy
+6,556
New +$334K 0.01% 427
2019
Q1
Sell
-280
Closed -$10K 821
2018
Q4
$10K Buy
+280
New +$10.2K ﹤0.01% 516

Other funds holding XRAY

Wealthspire Advisors (New York)'s XRAY Position: Q4 2025 in Review

Wealthspire Advisors (New York) sold out of Dentsply Sirona (XRAY) in Q4 2025, closing a stake of 1,158 shares — an estimated $14.7K sold.

Wealthspire Advisors (New York) first reported a position in XRAY in Q4 2018 and held it in 5 quarters. The position peaked at $269K in Q1 2021. 361 funds tracked by Wall St. Rank hold XRAY as of Q4 2025.

  • Wealthspire Advisors (New York) reported no remaining Dentsply Sirona position as of Q4 2025 after selling out during the quarter.
  • Wealthspire Advisors (New York) sold 1,158 Dentsply Sirona shares in Q4 2025, an estimated $14.7K.
  • Wealthspire Advisors (New York) first reported a position in Dentsply Sirona in Q4 2018 and held it in 5 quarters.
  • Wealthspire Advisors (New York)'s Dentsply Sirona position peaked at $269K in Q1 2021.
  • 361 funds tracked by Wall St. Rank held Dentsply Sirona as of Q4 2025.

Based on Wealthspire Advisors (New York)'s 13F filing for Q4 2025, filed 13 Feb 2026.